Author Question: One of the main challenges in caring for a patient with bronchiectasis is: a. contending with ... (Read 22 times)

jho37

  • Hero Member
  • *****
  • Posts: 531
One of the main challenges in caring for a patient with bronchiectasis is:
 
  a. contending with bronchospasm.
  b. removing excessive bronchopulmonary secretions.
  c. returning the FRC to within normal limits.
  d. maximizing gas exchange across the alveolar-capillary membrane.
  e. rehydrating dried secretions.

Question 2

The medication racemic epinephrine (Micronefrin, Vaponefrin) is given to a patient with LTB because it:
 
  a. is an effective bronchodilator.
  b. causes mucosal vasoconstriction.
  c. causes bradycardia.
  d. has an appealing taste and smell.



alvinum

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

B
The main challenge facing the respiratory therapist caring for the patient with bronchiectasis is the efficient removal of excessive bronchopulmonary secretions.

Answer to Question 2

B
Racemic epinephrine constricts the blood vessels in the mucous membrane of the airway. This helps to counteract the airway inflammation found in a patient with LTB. Although the drug is also a bronchodilator, it is not given for this effect. The drug may cause tachycardia as a side effect. There should not be any particular taste to the drug because it is nebulized.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

For a complete list of videos, visit our video library